# Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study

> **NCT03146858** · PHASE4 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 22 (actual)

## Conditions studied

- Primary Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT03146858
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-25
- **Primary completion:** 2017-12-30
- **Final completion:** 2018-03-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146858, "Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03146858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*